 |
|
|
| |
|
|
| |
191 West Burton Mesa Blvd
Suite A
Lompoc, CA 93436
Phone 805-733-2060
Toll Free 800-805-7360
Fax 805-733-2061 |
|
| |
|
|
|
|
|
|
|
|
DENTISTRY COMPOUNDING |
 |
|
At Agewell we customize each
prescription formulation
specifically to each
patients' individual
requirements. We
strive to provide the utmost
in customer care on every
order. Please call us
with any questions
pertaining to your
compounding request, we are
here to discuss any
questions or concerns you
may have pertaining to your
prescription.
Compounded
Medications:
-
Tetracaine
0.5% Solution in long
stem sprayer bottle
(various flavors) for
office use
-
Carbamide
Peroxide bleaching gels
-
Chlorhexidine
0.12% rinse,
alcohol-free, flavored
-
Deoxy
DG2 0.2% cream for cold
sores
-
Electrolyte Troches for
dry mouth
-
Oral Rinse #5 (contains:
nystatin, triamcinolone,
chlorpheniramine, and
(2)deoxy-d- glucose) for
apthous ulcers
-
Ketoprofen
2% oral gel
-
Chloral Hydrate gummy
stars, flavored
-
Hydroxyzine
gummy bears, flavAored
-
KLMP
cream (contains:
ketoprofen, lidocaine,
misoprostol, and
phenytoin) for healing
ulcers
-
Triamcinolone
0.2% Mouth Rinse,
flavored, for canker
sores
-
Lidocaine
4% mucosal bandage
-
Grossman’s Dental Sealer
|
Dexamethasone Suspension
-as a mouth rinse
-4mg per teaspoon
|
Triamcinolone Mouth Rinse
-triamcinolone 0.1% or
0.2% |
|
Lidocaine Rinse
-with misoprostol 0.0024%
(promotes healing)
-with trimcinolone 0.1%
-with maalox
|
Combination Rinses
-Apthous Ulcers
-Radiation Mucositis
|
|
Basic BLM Rinse
-Benadryl Elixir
-Lidocaine 2% viscous
-Maalox, Carafate or
Alovera liquid
-1-1-1
|
Oral Rinse
-nystatin
-etracycline
-chlorpheniramine
-triamcinolone
-deoxy-d-glucose
|
|
Miracle Mouthwash
-dexamethasone
-diphenhydramine
-nystatin
-tetracycline
|
Stanford Mouthwash
-nystatin
-tetracycline
-chlorpheniramine maleate
-hydrocortisone
|
|
Diphenhydramine Plus Oral
Gel
-diphenhydramine 5%
-deoxy-d-glucose .2%
-lidocaine 1%
|
Chloral Hydrate
-capsule 500mg
-suppository 500mg
-syrup 100mg/ml (1289)
-gummy stars
-gelatin troche
|
|
Hydroxyzine Pamoate
-syrup 25mg/5ml (0811)
-gummy bears 25mg
|
|
|
|
|
DRY MOUTH, STOMATIS
AND MUCOSITIS:
Treatment
for Dry Mouth,
Stomatitis, and
Mucositis
Loss of saliva (xerostomia)
is one of the most
common complaints
among patients who
have received
radiation therapy of
the head and neck.
Xerostomia
contributes to
radiation-induced
periodontal
infection, dental
caries,
osteoradionecrosis,
and poor digestion
of carbohydrates.
Ask us about
sialogogues (saliva
stimulants) in
customized dosage
forms.
Aust Dent J
2002
Sep;47(3):249-53
An
investigation into
the use of
pilocarpine as a
sialagogue in
patients with
radiation induced
xerostomia.
Frydrych AM,
Davies GR,
Slack-Smith LM,
Heywood J.
School of Dentistry,
The University of
Western Australia,
Crawley.
In order to access the
PubMed abstract of this
article, visit this
website link.
When a person is
receiving
chemotherapy or
radiation, mouth
tenderness and
infections can
interfere with the
ability to eat.
Malnutrition may
result, yet it is
often preventable.
Our pharmacy can
compound medications
which may enable
patients to enjoy
eating again. We can
compound numerous
medications into a
preparation such as
an oral rinse that
contains the needed
concentrations of
each drug.
A three-drug
mouthwash (lidocaine,
diphenhydramine and
sodium bicarbonate
in normal saline)
can provide
effective
symptomatic relief
in patients with
chemotherapy-induced
mucositis.
Support Care
Cancer. 2000
Jan;8(1):55-8
Efficacy of
treatment to relieve
mucositis-induced
discomfort.
Turhal NS, Erdal S,
Karacay S.
Department of
Medicine, Marmara
University Hospital,
Istanbul, Turkey.
In order to access the
PubMed abstract of this
article, visit this
website link.
|
|
|
|
|
MIRACLE MOUTHWASHES:
Compounding dental
mouthwashes or
rinses may offer
numerous advantages
over commercially
available dosage
forms. Elixirs,
syrups, and
suspensions often
contain
preservatives such
as alcohol which can
cause reactions or
gastrointestinal
irritation, or sugar
which makes the
preparation
undesirable for
prolonged use in the
mouth or for
diabetic patients. A
customized
preparation without
unnecessary
excipients - i.e., a
sugar-free,
dye-free,
lactose-free, and
preservative-free
dosage form - can
eliminate concerns
of palatability,
alcohol content, and
dyes which may stain
exposed mucosa.
Various preparations
are also available
to treat burning
mouth syndrome and
anesthetic/analgesic
and
antibiotic/anti-infective
mouthwashes are
commonly requested.
Tranexamic acid
solution (4.8%) used
as a mouthwash has
been used
successfully to
prevent postsurgical
bleeding after oral
surgery without dose
modification of oral
anticoagulants.
J Oral
Maxillofac Surg
1993
Nov;51(11):1211-6
Prevention
of postsurgical
bleeding in oral
surgery using
tranexamic acid
without dose
modification of oral
anticoagulants.
Ramstrom G,
Sindet-Pedersen S,
Hall G, Blomback M,
Alander U
Department of Oral
and Jaw Diseases,
Karolinska Hospital,
Stockholm, Sweden.
|
|
|
|
|
PERIODONTAL
THERAPY:
Compounding allows
countless active
ingredients to be
incorporated into
customized
mouthwashes, gels,
troches, etc. For
example, to treat
periodontal disease,
antibiotics can be
formulated as a
mouthwash, or added
to an oral adhesive
paste or a
plasticized gel that
will maintain the
contact between the
tissue and
medication for a
prolonged period of
time.
Metronidazole 25%
in a lipogel-type
base provides an
efficient treatment
of anaerobic
infection when
applied topically in
the periodontal
pockets.
Click on the
following citations
for abstracts/more
information:
J Int Acad
Periodontol. 2000
Jul;2(3):64-70
Vojnosanit Pregl.
2005
Jul-Aug;62(7-8):565-8
Minerva Stomatol.
2000
Jan-Feb;49(1-2):59-67
J Clin Periodontol.
1992 Oct;19(9 Pt
2):693-7
|
|
|
|
|
SUPPRESSING THE GAG
REFLEX:
The gag reflex can
cause a patient
considerable
discomfort as well
as interfere with
dental procedures.
An electrolyte
tablet administered
and retained
intraorally a few
minutes before the
start of a procedure
can suppress the gag
reflex, allowing a
mandibular block to
be given with much
greater ease, which
further reduces the
gagging reflex.
Tablets can be
prescribed for home
use for patients who
can not properly
perform oral hygiene
procedures due to
the gagging problem.
Severe gaggers may
need to repeat a
dose in 15 to 20
minutes. (Dent
Today. 1991
Dec;10(9):68-71)
Some patients and
dentists prefer to
use electrolyte
lollipops. |
|
|
|
|
THERAPY FOR TMJ:
We believe that
Transdermal
application of
NSAIDs such as
ketoprofen results
in significantly
higher tissue levels
beneath the site of
application than are
achieved with oral
administration.
Additionally, side
effects such as
gastrointestinal
irritation are
avoided.
The below mentioned article
describes how
topical non-steroidal
anti-inflammatory drugs are
effective in relieving pain
in acute and chronic
conditions.
BMJ. 1998
Jan
31;316(7128):333-8
Quantitative
systematic review of
topically applied
non-steroidal
anti-inflammatory
drugs.
Moore RA, Tramer MR,
Carroll D, Wiffen PJ,
McQuay HJ.
University of
Oxford, Oxford
Radcliffe Hospital,
Headington.
In order to access the
PubMed abstract of this
article, visit this
website link.
Free full text
article available at
bmj.com:
http://bmj.bmjjournals.com/cgi/content/full/316/7128/333
The following
article reports "The
systemic
concentrations of
ketoprofen have also
been found to be 100
fold lower compared
to tissue
concentrations below
the application...
Topically applied
ketoprofen thus
provides high local
concentration below
the site of
application but
lower systemic
exposure."
Pharm Res.
1996
Jan;13(1):168-72
The below mentioned
article
investigates the
Percutaneous
absorption of
ketoprofen from
different anatomical
sites in man.
Shah AK, Wei G,
Lanman RC, Bhargava
VO, Weir SJ.
Pfizer Inc., Central
Research Division,
Groton, Connecticut
06340, USA
In order to access the
PubMed abstract of this
article, visit this
website link.
Iontophoretic
delivery of
dexamethasone and
lidocaine may be
effective in
improving mandibular
function in patients
with
temporo-mandibular
disorders who have
concurrent
temporo-mandibular
joint capsulitis and
disc displacement
without reduction.
J Orofac Pain
1996
Spring;10(2):157-65
Temporomandibular
joint iontophoresis:
a double-blind
randomized clinical
trial.
Schiffman EL, Braun
BL, Lindgren BR.
TMJ and Craniofacial
Pain Clinic, School
of Dentistry
University of
Minnesota,
Minneapolis 55455
In order to access
the PubMed abstract
of this article,
visit this
website link. |
|
|
|
|
TOPICAL THERAPY
FOR PAIN AND
INFECTION:
Agewell Pharmacy
believes there are a
variety of options
to help patients
with oral and
perioral pain
problems such as
neuropathies,
burning mouth
syndrome, neuromas
and neuralgias.
Vehicle-carrier
agents and bases
have been developed
that can penetrate
the mucosa and
cutaneous tissues
and transport the
active medication to
the treatment site.
Dentists have been
using topical agents
with increasing
frequency as part of
the therapeutic
protocol for
orofacial painful
neuropathy.
Several topical
intraoral
medications are used
in the treatment of
oral ulcerations and
infections,
including
antifungals;
nonsteroidal
anti-inflammatory
drugs (NSAIDs); and
corticosteroids.
Because of their
rapid onset and low
side-effect profile,
topical medications
offer a distinct
advantage over
systemic
administration for
orofacial disorders.
Medicated lollipops,
lozenges, and
adhering powders are
ideal for keeping an
antibiotic or
antifungal in
contact with an
infected area in the
mouth.
Topical
Anesthetics
Methemoglobinemia (MHb)
is a potentially
serious blood
condition and an
uncommon adverse
reaction known to be
associated with
benzocaine. This
condition reduces
the ability of red
blood cells to
deliver oxygen
throughout the body,
which can lead to
bluish discoloration
of the skin, nausea
and fatigue. It can
progress to stupor,
coma and death.
Almost all reported
cases of benzocaine-induced
MHb were associated
with
high-concentration
preparations (14
percent to 20
percent benzocaine).
Compounding
pharmacies can
formulate low
concentration or
benzocaine-free
topical anesthetics,
including
combinations of
other topical
anesthetics such as
lidocaine and
tetracaine or
prilocaine.
Updade on
Burning Mouth
Syndrome
Burning
mouth syndrome
(BMS), also referred
to as glossopyrosis
or glossodynia (when
the burning occurs
on the tongue only)
is usually described
as oral burning
pain, sometimes with
dysesthetic
qualities similar to
those present in
other neuropathic
pain conditions. The
dorsal tongue,
palate, lips and
gingival tissues,
individually or in
combination, are the
most common sites
involved. Bilateral
or unilateral oral
burning pain has
been found to be
associated with jaw
pain or
uncontrollable
tightness, taste
changes, subjective
dry mouth,
geographic and
fissured tongue,
painful teeth,
headache, neck and
shoulder pain,
difficulty speaking,
nausea, gagging and
swallowing
difficulties. BMS
has been reported to
follow dental
treatment,
antibiotic usage and
a severe upper
respiratory
infection. The lack
of pathology to
account for the pain
can be frustrating.
Pain is constant,
progressively
increases over the
day, and usually
decreases during
eating. Patients,
who are frequently
distressed by their
unremitting
symptoms, may
demonstrate
psychological
abnormalities
including anxiety
and depression.
Therapy for BMS
involves the use of
centrally acting
medications for
neuropathic pain,
such as tricyclic
antidepressants,
benzodiazepines or
gabapentin.
Clonazepam is a
benzodiazepine used
either topically or
in low doses orally,
which appears to
have excellent
efficacy in the
relief of the
symptoms related to
BMS. Topical
medications,
including clonidine,
may be considered
for application to
local sites.
A combination of
oral medications for
the management of
BMS (clonazepam,
gabapentin, baclofen,
and lamotrigine)
significantly
decreased pain in 38
or 45 patients. The
most common adverse
effect reported with
the medication
protocol was
drowsiness followed
by dizziness and
perceived changes in
mood. These results
suggest that BMS may
be treated with
lower doses of a
combination of
medications rather
than higher doses of
a single medication,
which may help to
limit adverse
effects such as
drowsiness or
dizziness.
Adv Otorhinolaryngol.
2006, 63:278-287
The formulation for
a mouthrinse
containing
clonazepam 1 mg per
5 ml has been
reported. It is
hypothesised that
clonazepam acts
locally to disrupt
the mechanism(s)
underlying
stomatodynia.
Topical formulations
of gabapentin,
ketamine, clonidine,
and baclofen have
been used to treat
chronic neuropathic
pain at various
bodily sites.
Int J of
Pharmaceutical
Compounding July/Aug
2005, 9(4):310
In order to access the
PubMed abstract of this
article, visit this
website link.
Pain Med. 2000
Mar;1(1):97-100
|
|
|
|
|
TRANSDERMAL
ANTI-EMETICS:
Topical application
of anti-emetics in a
gel formulation
provides a rapid
onset and offers an
effective
alternative to oral
administration. Oral
surgeons have found
this formulation to
be particularly
useful.
Promethazine is
commonly compounded
for topical or
transdermal
application to treat
nausea, vomiting,
and vertigo, but
this preparation may
be used as an
antiemetic for cases
ranging from
chemotherapy to
motion sickness. The
dose is typically
25mg for adults, and
the dose is
decreased for
children. The gel is
applied to an area
of soft skin, such
as the inside of the
wrist or arm, the
side of the torso,
or the inside of the
thigh. For children,
the gel is often
applied to the
inside of one wrist,
and then the wrists
are rubbed together.
US Pharmacist,
August 1999; 74-5
Other dosage forms
include
suppositories and
lollipops.
|
|
|
|
|
|
|
|
|
|
|
|
 |